Ind-Swift Laboratories Ltd
NSE: INDSWFTLAB BSE: 532305
₹141.51
(-0.41%)
Sat, 21 Mar 2026, 09:11 pm
Market Cap11.57B
PE Ratio4.24
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KInd-Swift Laboratories Financials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.15B | 3.50B | 4.47B | 5.84B | 7.76B | 10.35B | 14.09B | 11.35B | 9.65B | 6.60B | 6.53B | 6.97B | 7.65B | 7.57B | 7.80B | 8.91B | 10.39B | 12.07B | 17.09B | 5.62B |
| Gross profit | 570.02M | 520.38M | 640.00M | 962.31M | 1.25B | 1.75B | 1.87B | 798.02M | 458.87M | 575.21M | 970.64M | 863.10M | 1.34B | 950.70M | 1.37B | 1.90B | 1.61B | 2.57B | 4.06B | 931.10M |
| Operating expenses (excl. COGS) | -67.30M | -4.76M | -88.60M | -62.75M | -332.89M | -422.14M | -487.09M | -624.91M | -526.02M | -529.69M | -745.34M | -685.04M | -866.81M | -729.58M | -820.56M | -928.04M | -826.69M | -836.56M | -1.80B | -1.35B |
| Selling/general/admin expenses, total | — | — | -36.84M | — | -326.71M | -383.59M | -465.97M | -594.00M | -497.64M | -503.48M | -717.50M | -679.14M | -843.55M | -726.55M | -818.00M | -919.42M | -805.18M | -798.85M | -1.75B | -1.27B |
| Research & development | -63.32M | -54.45M | -36.84M | -49.38M | -52.27M | -56.84M | -67.32M | -76.04M | -77.94M | -82.16M | -95.65M | -105.17M | -300.64M | -207.06M | -302.15M | -330.13M | -327.16M | -425.74M | -355.17M | — |
| Selling/general/admin expenses, other | — | — | — | — | -274.44M | -326.75M | -398.65M | -517.96M | -419.71M | -421.32M | -621.85M | -573.97M | -542.90M | -519.49M | -515.85M | -589.29M | -478.02M | -373.12M | -1.75B | -1.27B |
| Other operating expenses, total | -67.30M | -4.76M | -51.77M | -62.75M | -6.18M | -38.55M | -21.13M | -30.91M | -28.38M | -26.21M | -27.84M | -5.91M | -23.26M | -3.03M | -2.56M | -8.62M | -21.51M | -37.71M | -51.02M | -78.54M |
| Operating income | 502.73M | 461.16M | 551.40M | 899.56M | 913.91M | 1.33B | 1.38B | 173.12M | -67.15M | 45.52M | 225.30M | 178.06M | 478.09M | 221.12M | 548.04M | 971.51M | 785.09M | 1.74B | 2.26B | -422.18M |
| Non-operating income, total | -107.43M | -219.44M | -159.93M | -407.18M | -382.92M | -439.38M | -518.06M | -1.36B | -1.35B | -1.48B | -1.05B | -731.08M | -118.23M | 275.65M | -745.75M | -791.43M | -659.77M | -870.19M | 3.72B | 3.00B |
| Interest expense, net of interest capitalized | -105.43M | -234.65M | -261.21M | -384.17M | -301.69M | -331.37M | -495.42M | -727.37M | -1.20B | -1.17B | -1.06B | -902.67M | -282.08M | -922.02M | -1.07B | -1.00B | -955.46M | -921.66M | -1.04B | -29.19M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 158.35M | 30.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 2.21M | 17.53M | 100.73M | 6.40M | -57.82M | -107.36M | -20.55M | -492.80M | 172.11M | 221.75M | 159.10M | 224.99M | 183.22M | 1.20B | 329.12M | 210.74M | 366.70M | 61.48M | 4.76B | 3.03B |
| Non-operating interest income | 9.20M | 19.92M | — | — | — | 61.42M | 127.34M | 36.14M | 34.46M | 35.56M | 7.11M | 9.21M | 38.46M | 27.07M | 5.30M | 5.13M | 5.62M | 58.72M | 100.49M | 382.69M |
| Miscellaneous non-operating expense | -6.99M | -2.40M | 100.73M | 6.40M | -57.82M | -168.78M | -147.89M | -528.94M | 137.65M | 186.20M | 151.99M | 224.99M | 144.75M | 1.17B | 323.82M | 205.61M | 361.08M | 2.76M | 4.66B | 2.65B |
| Unusual income/expense | -4.21M | -2.32M | 552.44K | -29.41M | -23.40M | -647.77K | -2.09M | -141.36M | -327.13M | -527.92M | -148.04M | -53.39M | -19.36M | 0 | 0 | 0 | -71.01M | -10.00M | 0 | 0 |
| Pretax income | 395.30M | 241.73M | 391.47M | 492.38M | 530.99M | 889.88M | 865.47M | -1.19B | -1.42B | -1.43B | -827.80M | -553.02M | 359.86M | 496.77M | -197.71M | 180.09M | 125.32M | 865.21M | 5.98B | 2.58B |
| Taxes | -60.35M | -59.34M | -77.26M | -88.46M | 32.87M | 4.74M | 26.14M | 8.77M | 200.51M | 240.01M | 240.92M | 161.68M | -140.10M | -207.31M | -14.17M | -211.56M | -146.81M | -386.90M | -589.81M | -72.70M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 2.23M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 334.95M | 182.39M | 314.21M | 403.92M | 563.86M | 894.62M | 891.61M | -1.18B | -1.22B | -1.19B | -584.65M | -391.34M | 219.76M | 289.46M | -211.88M | -31.47M | -21.49M | 475.97M | 5.39B | 2.50B |
| Net income | 334.95M | 182.39M | 314.21M | 403.92M | 563.86M | 894.62M | 891.61M | -1.18B | -1.22B | -1.19B | -584.65M | -391.34M | 219.76M | 289.46M | -211.88M | -31.47M | -21.49M | 475.97M | 5.39B | 2.50B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36.36M | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 399.68K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 334.55M | 182.39M | 314.21M | 403.92M | 563.86M | 894.62M | 891.61M | -1.18B | -1.22B | -1.19B | -584.65M | -391.34M | 219.76M | 325.83M | -211.88M | -31.47M | -21.49M | 475.97M | 5.39B | 2.50B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 621.07M | 671.75M | 817.38M | 1.17B | 1.28B | 1.72B | 1.78B | 716.62M | 590.50M | 888.42M | 1.07B | 1.06B | 1.34B | 1.26B | 1.45B | 1.84B | 2.10B | 2.31B | 3.07B | -177.38M |
| EBIT | 502.73M | 461.16M | 551.40M | 899.56M | 913.91M | 1.33B | 1.38B | 173.12M | -67.15M | 45.52M | 225.30M | 178.06M | 478.09M | 221.12M | 548.04M | 971.51M | 785.09M | 1.74B | 2.26B | -422.18M |
| Total operating expenses | -2.64B | -3.04B | -3.92B | -4.94B | -6.85B | -9.02B | -12.71B | -11.17B | -9.72B | -6.56B | -6.31B | -6.80B | -7.18B | -7.34B | -7.25B | -7.94B | -9.60B | -10.34B | -14.83B | -6.04B |
| Prepaid expenses | 20.79M | 35.92M | 69.96M | 47.15M | 49.38M | 67.16M | 90.04M | 75.75M | 38.66M | 38.06M | 42.03M | 42.21M | 9.54M | 101.15M | 95.03M | 124.29M | 161.95M | 134.86M | 102.11M | 158.78M |
| Deferred income, current | — | — | — | — | — | — | — | — | 92.83M | 508.90M | 169.09M | 36.29M | 61.84M | 39.11M | 93.46M | 178.23M | 147.13M | 153.26M | 567.12M | 249.31M |
| Capital and operating lease obligations | 0 | 0 | 33.15M | 0 | 0 | 21.80M | 0 | 0 | 10.70M | 2.30M | 0 | 0 | 0 | 4.61M | 4.61M | 4.82M | 5.33M | 5.33M | 2.27M | 2.27M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 334.77M | 503.38M | 328.99M | 475.07M | 438.00M | 782.53M | 411.07M | 394.18M | 189.63M | — | 1.49B | 1.44B | 1.15B | 1.04B | 871.48M | 734.03M | 492.47M | 442.65M | 4.44M | 289.04M |
| Deferred income, non-current | — | 0 | 0 | 0 | — | — | — | — | — | 0 | — | 0 | 0 | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -897.00K | -1.10M | 0 | -171.00K | -348.00K |
| Change in accrued expenses | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -24.52M | -33.18M | -22.84M | -24.03M | -25.97M | -27.85M | -34.22M | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | -351.00K | -351.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800